NFKB2 is a key component of the non-canonical NF-κB pathway, and this pathway activity (assessed by NIK, IKKα and RelB staining) was shown to be associated with poor survival in ccRCC patients [29]. The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.